Chime Biologics, a leading global CDMO that enables its partners' success in biologics, today announced its continued ...

Net product sales of CAPLYTA were $680.5 million for the full year 2024. This represents an increase of 47% compared to 2023.

Neurofilament light (NFL) is a powerful and sensitive biomarker for tracking neuronal health and disease progression.

The field of central nervous system (CNS) drug development is awash with activity. And major new centres of research are ...

Researchers’ understanding of the pathogenesis of rheumatoid arthritis has grown considerably in recent years, laying the ...

The patch-delivered vaccine trial received $28.5m in funding from US authorities as a potential pandemic preparation.

Scientists have developed a new mRNA vaccine to treat pancreatic cancer that may extend patients' lifespans by 8 to 10 years.

What factors influence the success or failure of immunotherapy treatment in patients with advanced bladder cancer? Why do ...

The FARE Innovation Award Diagnostic Challenge is made possible through generous support from the Naddisy Foundation, the ...

More than 2 years after the child was born, no identifiable features of SMA have been observed, reported Richard Finkel, MD, of St. Jude Children's Research Hospital in Memphis, Tennessee, and ...

Among patients with pulmonary arterial hypertension treated with 72-week seralutinib, those deemed responders had more improved measures, according to a poster presented at the Pulmonary Vascular ...

TMC114FD1HTX1002.11 We include the results of that analysis here to compare to the results with those of phase 2, 3, and 4 trials. This new research is intended to complement the earlier publication ...